Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis

Figure 1 Flow diagram of study selection.

Figure 2 Quality assessments of included studies. A: Risk of bias summary; B: Risk of bias graph.

Figure 3 Forest plots of the meta-analysis of clinical response rate. A: Pooled of all intervention groups; B: Drug dose: 2 mg/kg; C: Drug dose: 6 mg/kg.

Figure 4 Forest plot of the meta-analysis of clinical remission rate.

Figure 5 Forest plot of the meta-analysis of serious adverse events.

Figure 6 Sensitivity analysis for the influence of individual studies on pooled estimates as determined using the leave-one-out method. A: Clinical response rate; B: Clinical remission rate; C: Serious adverse event rate.